Mosaic Therapeutics
PrivateLast Round
Strategic
Apr 24, 2025
Total Funding Raised
$28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mosaic Therapeutics is a biotechnology company that develops targeted oncology therapies for patient groups with unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mosaic Therapeutics Comparables
Compare Mosaic Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enedra Therapeutics | 88% | |
| Evariste | 83% | |
| Eisbach Bio GmbH | 83% |
Mosaic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 24, 2025 | ||||
| Series A | Apr 4, 2023 |
Key People
Founding team and executive leadership
Mosaic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cambridge Innovation Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 96% MoM, reaching 1.5K.
- Jan 1, 2026
Preclinical data for lead program MOS101 disclosed at AACR Annual Meeting 2026.
Recent news
Latest coverage and updates
- is_developingAug 4, 2026
Mosaic Therapeutics LTD is developing MDM2 antagonist on Apr 1st '25.
- hiresAug 4, 2026
Mosaic Therapeutics LTD hired Allison Jeynes as Chair of the Board on Aug 4th '26.
Mosaic Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mosaic Therapeutics's valuation, stock price, and market status.
Is Mosaic Therapeutics a public or private company?
Mosaic Therapeutics is a private company.
What is the current stock price of Mosaic Therapeutics?
Mosaic Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Mosaic Therapeutics worth (valuation)?
Valuation information for Mosaic Therapeutics is not publicly available.
Can I buy Mosaic Therapeutics stock?
Mosaic Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mosaic Therapeutics's last funding round?
Mosaic Therapeutics's most recent funding round was Strategic on April 24, 2025.
Who are the main investors in Mosaic Therapeutics?
Key investors in Mosaic Therapeutics include Cambridge Innovation Capital.
Will Mosaic Therapeutics IPO soon?
No public IPO plans have been announced for Mosaic Therapeutics.
How can I track Mosaic Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mosaic Therapeutics's secondary market activity and sign up for updates.